Impairment of energy metabolism and excitotoxic cell death in Huntington's disease

Revue Neurologique

Volumn 153, Issue 8-9, 1997, Pages 496-498

  Young, A B ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Massachusett General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DEATH; ENERGY EXPENDITURE; FRANCE; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; PATHOPHYSIOLOGY;

APOPTOSIS; ENERGY METABOLISM; HUMANS; HUNTINGTON DISEASE; NEURONS;

EID: 0030869919     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. BEAL M.F., BROUILLET E., JENKIMS B.G. et al. (1993). Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the nmitochondrial toxin 3-nitropropionic acid. J Neurosci, 13 : 4181-4192.
2. BROUILLET E., HANTRAYE P., FERRANTE R. et al. (1995). Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci (USA), 92 : 7105-7109.
3. BURKE J.R., ENGHILD J.J., MARTIN M.E. et al. (1996). Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med, 2 : 347-350.
4. FURTADO S., SUCHEROWSKY O., REWSASLE N.B. et al. (1996). Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol, 39 : 132-136.
5. Gu M., GASH M.T., MANN V.M. et al. (1996). Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol, 39 : 385-389.
6. HEDREEN J.C., FOLSTEIN S.E. (1995). Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol, 54 : 105-120.
7. HUNTINGTON'S DISEASE COLLABORATIVE RESEARCH GROUP (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72 : 971-983.
8. JENKINS B.G., KOROSHETZ W.J., BEAL M.F., ROSEN B.R. (1992). Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology, 43 : 2689-2695.
9. LANDWEHRMEYER G.B., STANDAERT D.G., TESTA C.M. et al. (1995). NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci, 15 : 5297-5307.
10. MACDONALD M.E., BARNEW G., SRINIDHI J. et al. (1993). Gametic but not somatic instability of CAG repeat length in Huntington's disease. J Med Genet, 30 : 982-986.
11. ORLANDO L.R., STANDAERT D.G., PENNEY J.B., YOUNG A.B. (1995). (S)-4-Carboxy-3-hydroxyphenylglycine ((S)-4C3HPG) protects against rat striatal quinolinic acid lesions. Neurosci Letts, 202 : 109-112.
12. PERUTZ M.F., JOHNSON T., SUZUKI M. et al. (1994). Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci (USA), 91 : 5355-5358.
13. SHARP A.H., Ross C.A. et al. (1996). Neurobiology of Huntington's disease. Neurobiol Disease, 3 : 3-15.
14. TESTA C.M., STANDAERT D.G., LANDWEHRMEYER G.B. et al. (1995). Differential expression of the mGluR5 metabotropic receptor by rat striatal neurons. J Comp Neurol, 354 : 241-252.